Intel’s planned $5.4 billion acquisition of Israeli contract chipmaker Tower Semiconductor has been mutually called off due to challenges in obtaining timely regulatory approvals. As a result, Tower Semiconductor’s shares experienced a 9% drop both in the United States and Tel Aviv.
Under the terms of the termination, Intel will pay Tower Semiconductor a fee of $353 million. While the exact details of the regulatory issues were not disclosed, the termination highlights how geopolitical tensions between the United States and China can impact corporate mergers and acquisitions in the technology sector.
The failed deal underscores the difficulties technology companies face in navigating cross-border regulatory challenges. This development comes after other similar deals have faced hurdles due to regulatory approval delays, reflecting broader international trade and political concerns.
Despite the termination of the Tower Semiconductor deal, Intel remains committed to its foundry business, which produces chips for other companies. The company recently reported a significant revenue increase in its foundry business, driven by advanced packaging techniques that enhance chip performance.
Intel’s decision to terminate the deal also comes in the context of a shift in demand for its chips, as the remote work-driven surge in demand during the pandemic has subsided. As a result, Intel is pursuing cost-cutting measures to optimize its operations and maintain competitiveness in the semiconductor industry.
